MyCIT

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MyCIT was filed as Word mark on 07/01/2019 at the World Intellectual Property Organization.

Trademark Details Last update: August 25, 2022

Trademark form Word mark
File reference 1487709
Register number 302019000083
Countries Australia Canada European Community Japan United States of America (USA)
Base trademark DE No. 30 2019 000 083, March 19, 2019
Application date July 1, 2019
Expiration date July 1, 2029

Trademark owner

An der Goldgrube 12
55131 Mainz
DE

Trademark representatives

Prinzregentenstr. 74 81675 Munich DE

goods and services

05 Pharmaceutical products for the treatment of cancer, in particular based on nucleic acids and/or proteins; personalised patient-specific medicinal products, in particular based on nucleic acids and/or proteins
09 Scientific apparatuses and instruments; software algorithms as software programs, in particular for the detection and collection of mutations in cancer patients
10 High-throughput analytical instruments, in particular instruments for next-generation sequencing [NGS] for medical issues, as well as for gene expression profiling and for the detection of epigenetic changes
42 Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biological, genetic, biotechnological and/or bioinformatic methods, in particular by means of next-generation sequencing; diagnostics of tumour markers für personalised treatment as scientific laboratory services or as part of scientific research for medical purposes
44 Medical, veterinary-medical and pharmaceutical advisory services, in particular in the selection of suitable treatments for cancer diseases of all kinds; performance of analyses and treatments as part of personalised cancer immunotherapy; provision of treatments based on nucleic acids and/or checkpoint inhibitors

Trademark history

Date Document number Area Entry
August 3, 2022 2022/34 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 25, 2022 2022/13 Gaz Deletion
April 22, 2021 2021/17 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 12, 2021 2021/3 Gaz CA Rejection
December 2, 2020 2020/49 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 22, 2020 2020/43 Gaz JP Rejection
September 3, 2020 2020/37 Gaz CH Rejection
March 18, 2020 2020/12 Gaz AU Rejection
February 21, 2020 2020/9 Gaz EM Rejection
October 7, 2019 2019/41 Gaz US Rejection
July 1, 2019 2019/36 Gaz DE Registration

ID: 141487709